Patent ID: 9175094
Filing Date: 2015-11-03
Classification: A61K,A61P,C07H,C07K,G01N

Abstract:
1. A method for treating a disease or disorder which is caused by or associated with amyloid or amyloid-like proteins, comprising administering to a subject in need thereof: (a) a monoclonal antibody, or an active fragment thereof, which is produced by hybridoma cell line FG1F9E4, deposited on May 25, 2007 and given deposit number DSM ACC2845; (b) a monoclonal antibody, or an active fragment thereof, which is produced by hybridoma cell line FK2A6A6, deposited on May 25, 2007 and given deposit number DSM ACC2846; or (c) an anti-amyloid beta antibody, or active fragment thereof, wherein